Search

Your search keyword '"Rickettsia conorii immunology"' showing total 96 results

Search Constraints

Start Over You searched for: Descriptor "Rickettsia conorii immunology" Remove constraint Descriptor: "Rickettsia conorii immunology"
96 results on '"Rickettsia conorii immunology"'

Search Results

1. Cervids as Sentinels for Rickettsia spp. in Portugal.

2. [Fever and eruption in 2 neighbors].

3. Clinical case of spotted fever group rickettsiae.

4. Rickettsia conorii O antigen is the target of bactericidal Weil-Felix antibodies.

5. Macrophages Infected by a Pathogen and a Non-pathogen Spotted Fever Group Rickettsia Reveal Differential Reprogramming Signatures Early in Infection.

6. Ocular manifestations of Rickettsia conorii in South India.

7. Identification of rickettsial immunoreactive proteins using a proximity ligation assay Western blotting and the traditional immunoproteomic approach.

8. African tick-bite fever - a tantalizing souvenir from South Africa.

9. Widespread subcutaneous necrosis in spotted fever group Rickettsioses from the coastal belt of Sri Lanka- a case report.

10. Rickettsial seropositivity in the indigenous community and animal farm workers, and vector surveillance in Peninsular Malaysia.

11. Rickettsia conorii is a potent complement activator in vivo and combined inhibition of complement and CD14 is required for attenuation of the cytokine response ex vivo.

12. Prevalence of antibodies to Rickettsia conorii in human beings and dogs from Catalonia: a 20-year perspective.

13. An embedded microretroreflector-based microfluidic immunoassay platform.

14. Shell-vial culture, coupled with real-time PCR, applied to Rickettsia conorii and Rickettsia massiliae-Bar29 detection, improving the diagnosis of the Mediterranean spotted fever.

15. A case of uveitis due to Rickettsia conorii infection in Southeastern France.

16. Failure of a heterologous recombinant Sca5/OmpB protein-based vaccine to elicit effective protective immunity against Rickettsia rickettsii infections in C3H/HeN mice.

17. A case of Mediterranean spotted fever associated with severe respiratory distress syndrome.

18. Evaluation of a new serological test for the detection of anti-Coxiella and anti-Rickettsia antibodies.

19. Molecular and serological study of rickettsial infection in humans, and in wild and farm animals, in the province of Burgos, Spain.

20. Pathogenic Rickettsia species acquire vitronectin from human serum to promote resistance to complement-mediated killing.

21. Clinico-epidemiological profile of seven adults with spotted fever from a tertiary care hospital in South India.

22. Rickettsial meningitis.

23. Skin lesions and inoculation eschars at the tick bite site in spotted fever group rickettsioses: experience from a patient series in eastern crete, Greece.

24. Macular hole following Rickettsia conorii infection.

25. Detection of natural killer T cells in mice infected with Rickettsia conorii.

26. Serological evidence for exposure of dogs to Rickettsia conorii, Rickettsia typhi, and Orientia tsutsugamushi in Sri Lanka.

27. Suppressor of cytokine signalling protein SOCS1 and UBP43 regulate the expression of type I interferon-stimulated genes in human microvascular endothelial cells infected with Rickettsia conorii.

28. Changes of Bcl-2, Bax and Caspase-3 expression in the dermal microvascular endothelial cells and the epidermal layers of the eschar (tache noire) in patients with Mediterranean spotted fever.

29. Cross-protection among Rickettsia species and subspecies in a guinea pig model of cutaneous infection.

30. Prevalence of antibodies against Rickettsia conorii, Babesia canis, Ehrlichia canis, and Anaplasma phagocytophilum antigens in dogs from the Stretto di Messina area (Italy).

31. Clinically helpful rickettsial disease diagnostic IgG titers in relation to duration of illness in an endemic setting in Sri Lanka.

32. The rickettsial OmpB β-peptide of Rickettsia conorii is sufficient to facilitate factor H-mediated serum resistance.

33. A case series of spotted fever rickettsiosis with neurological manifestations in Sri Lanka.

34. A complex interaction between Rickettsia conorii and Dickkopf-1--potential role in immune evasion mechanisms in endothelial cells.

35. Seroprevalence of Rickettsia typhi and Rickettsia conorii infections in the Canary Islands (Spain).

36. Molecular basis of immunity to rickettsial infection conferred through outer membrane protein B.

37. Detection of Rickettsia conorii strains in Portuguese dogs (Canis familiaris).

38. [Emergence of tick-borne spotted fever group rickettsiosis in Moscow].

39. [Meningoencephalitis caused by Rickettsia conorii in a young infant].

40. Rats as indicators of the presence and dispersal of six zoonotic microbial agents in Cyprus, an island ecosystem: a seroepidemiological study.

41. Atypical case of Mediterranean spotted fever.

42. Spotted fever group rickettsioses documented in Morocco.

43. Epidemiological study of rickettsial infections in patients with hypertransaminemia in Madrid (Spain).

44. CD4+ CD25+ Foxp3- T-regulatory cells produce both gamma interferon and interleukin-10 during acute severe murine spotted fever rickettsiosis.

45. Unusual pancytopenia secondary to haemophagocytosis syndrome in rickettsioses.

46. Question: can you identify this condition?

47. Rickettsioses presenting as major joint arthritis and erythema nodosum: description of four patients.

48. Development of recombinant OmpA and OmpB proteins as diagnostic antigens for rickettsial disease.

49. Rickettsial diseases in Haryana: not an uncommon entity.

50. Rickettsiae stimulate dendritic cells through toll-like receptor 4, leading to enhanced NK cell activation in vivo.

Catalog

Books, media, physical & digital resources